BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23009731)

  • 1. Outcomes in patients tested for Clostridium difficile toxins.
    Polage CR; Chin DL; Leslie JL; Tang J; Cohen SH; Solnick JV
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):369-73. PubMed ID: 23009731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
    Humphries RM; Uslan DZ; Rubin Z
    J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile infection in children hospitalized due to diarrhea.
    Dulęba K; Pawłowska M; Wietlicka-Piszcz M
    Eur J Clin Microbiol Infect Dis; 2014 Feb; 33(2):201-9. PubMed ID: 24213847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.
    Polage CR; Gyorke CE; Kennedy MA; Leslie JL; Chin DL; Wang S; Nguyen HH; Huang B; Tang YW; Lee LW; Kim K; Taylor S; Romano PS; Panacek EA; Goodell PB; Solnick JV; Cohen SH
    JAMA Intern Med; 2015 Nov; 175(11):1792-801. PubMed ID: 26348734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.
    Kim J; Pai H; Seo MR; Kang JO
    J Korean Med Sci; 2011 Oct; 26(10):1258-64. PubMed ID: 22022175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
    Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
    Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.
    Kwon JH; Reske KA; Hink T; Burnham CA; Dubberke ER
    J Clin Microbiol; 2017 Feb; 55(2):596-605. PubMed ID: 27927930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Clostridium difficile-suspected diarrhea in a French university hospital.
    Khanafer N; Vanhems P; Barbut F; Eckert C; Perraud M; Vandenesch F; Luxemburger C; Demont C;
    Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2123-2130. PubMed ID: 30120646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, epidemiology and control of
    Singhal T; Shah S; Tejam R; Thakkar P
    Indian J Med Microbiol; 2018; 36(3):381-384. PubMed ID: 30429391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence and clinical symptomatology of Clostridium difficile infections in a community setting in a cohort of Danish patients attending general practice.
    Søes LM; Holt HM; Böttiger B; Nielsen HV; Torpdahl M; Nielsen EM; Ethelberg S; Mølbak K; Andreasen V; Kemp M; Olsen KE
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):957-67. PubMed ID: 24352841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of inpatients Clostridium difficile prevalence and risk factors in Cameroon.
    Djuikoue IC; Tambo E; Tazemda G; Njajou O; Makoudjou D; Sokeng V; Wandji M; Tomi C; Nanfack A; Dayomo A; Lacmago S; Tassadjo F; Sipowo RT; Kakam C; Djoko AB; Assob CN; Andremont A; Barbut F
    Infect Dis Poverty; 2020 Aug; 9(1):122. PubMed ID: 32867842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.
    Boyanton BL; Sural P; Loomis CR; Pesta C; Gonzalez-Krellwitz L; Robinson-Dunn B; Riska P
    J Clin Microbiol; 2012 Mar; 50(3):640-5. PubMed ID: 22189114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Clostridium difficile infection "intervention": change in toxin assay results in fewer C difficile infection cases without changes in patient outcomes.
    Han Z; McMullen KM; Russo AJ; Copper SM; Warren DK; Dubberke ER
    Am J Infect Control; 2012 May; 40(4):349-53. PubMed ID: 21794950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
    Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
    Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of Clostridium difficile in antibiotic-associated-diarrhea patients.
    Naaber P; Stsepetova J; Smidt I; Rätsep M; Kõljalg S; Lõivukene K; Jaanimäe L; Löhr IH; Natås OB; Truusalu K; Sepp E
    J Clin Microbiol; 2011 Oct; 49(10):3656-8. PubMed ID: 21865427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrhea.
    Dubberke ER; Reske KA; Hink T; Kwon JH; Cass C; Bongu J; Burnham CD; Henderson JP
    Infect Control Hosp Epidemiol; 2018 Nov; 39(11):1330-1333. PubMed ID: 30226126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality.
    Boone JH; Archbald-Pannone LR; Wickham KN; Carman RJ; Guerrant RL; Franck CT; Lyerly DM
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):1045-51. PubMed ID: 24449345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Evaluation of the Performance of C. Diff Quik Chek Complete and Toxin A + B (Clostridium difficile) DUO Diagnostic Tests Compared with Toxigenic Culture in the Diagnosis of Clostridium difficile Infection.
    Yazisiz H; Özyurt ÖK; Öngüt G; Baysan BÖ; Dönmez L; Günseren F; Çolak D; Öğünç D
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.